Skip to content
Company Atlas

Events/Communication· News release

Hithink RoyalFlush reports multiple corporate updates including share减持, logistics, and drug trial approvals

Hithink RoyalFlush Information Network10jqka.com.cnCN detected

Detected multiple corporate announcements on the homepage: Shanghai Dongxing plans to reduce holdings by up to 3% in Shandong Glass Fiber; China's express delivery index rose 1.5% in August; Yidu Technology's affiliate won a RMB 3.565 million government contract; and Kangze Pharma's drug CMS-D001 received clinical trial approval for SLE. All updates are publicly disclosed and time-stamped.

Evidence

Before

not previously observed

After

Multiple corporate updates including share减持, logistics, and drug trial approvals

Confidence
High confidence90 %
Importance
70 / 100
Detected
14 Sept 2026 10:26 UTC
Surface
Homepage
Origin
llm· qwen3-4b-instruct-2507-4bitqwen3-4b-instruct-2507-4bit · prompt change-classifier/v1 — LLM-enriched interpretation of a deterministic change
Tags
financialnewsclinicalchinallm

Sources (1)

View block-level change diff →SensorCompany timeline

event evt_01M2FQA7BBP0D530VF58MQA0QT · cluster cl_01M2FQA7BF5YJSBVAJF3EGG22C · change chg_01M2FQ9B8YHXDDPHJH15SY0QKV · sensor sen_01M2D9W9Q2YTT3CTZN9Y4ATPN1

Underlying change

meaningful 0.55+42 / −42 / ~4 blockson homepage · 14 Sept 2026 10:26 UTCOpen block-level diff →
Structured payload & entities
{
  "payload": {
    "llm": {
      "confidence": 0.95,
      "importance": 0.7,
      "is_material": true
    },
    "entity_key": "Hithink RoyalFlush reports multiple corporate updates including share减持, logistics, and drug trial approvals",
    "change_kind": "meaningful",
    "significance": 0.5449000000953674
  },
  "entities": {
    "plans": [],
    "people": [],
    "amounts": [
      "356.5万元",
      "3.00%"
    ],
    "products": [],
    "locations": [
      "Shandong",
      "Hangzhou"
    ],
    "organizations": [
      "Shandong Glass Fiber",
      "Yidu Technology",
      "Kangze Pharma",
      "NMPA",
      "China Post Office"
    ]
  }
}
Hithink RoyalFlush reports multiple corporate updates including share减持, logistics, and drug trial approvals | Company Atlas